Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Apostolos Raptis"'
Autor:
John Spiliotis, Vasileios Charalampakis, Dimitrios Farmakis, Maria Gianniri, Apostolos Raptis, Panagiotis Fotiadis, Faidon Chrysovergidis, Harris Margari
Gastric cancer (GC) is a common malignancy and one of the leading causes of cancer related death. Peritoneal metastases (PM) are not uncommon and then prognosis is poor. Treatment options in these cases are not standardized. The use of cytoreductive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78d3093171031f20955e60f57b7781af
Autor:
null John Spiliotis, null George Dadoudis, null Christos Koupanis, null Mary Gianniri, null Pinelopi Stefanopoulou, null Dimitrios Farmakis, null Apostolos Raptis, null Dimitrios Vaikos
Publikováno v:
International Journal of Frontiers in Medicine and Surgery Research. 1:001-004
Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) results in significant morbidity and mortality and readmission. Previous studies have been limited with numbers or leak of tumor details. We analyzed a 15 year experien
Autor:
John, Spiliotis, Vasileios, Kalles, Anastasia, Prodromidou, Apostolos, Raptis, Marios, Ferfelis, Athina, Christopoulou, Marios, Tsiatas
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(4)
Combining cytoreductive surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) can benefit patients with peritoneal metastasis from colorectal cancer, however the optimal choice of the HIPEC chemotherapy is still under debate. The prese
Autor:
John Spiliotis, Nikolaos Kopanakis, Apostolos Raptis, Vasileios Kalles, Ioannis Kyriazanos, Athina Christopoulou, Alexios Terra, Anastasia Prodromidou
Publikováno v:
Pleura and Peritoneum
BackgroundCombining cytoreductive surgery (CRS) with Hyperthermic IntraPeritoneal Chemotherapy (HIPEC) can benefit patients with peritoneal metastasis from colorectal cancer. The present study evaluates the small bowel subset of the Peritoneal Cancer
Autor:
Dimitrios Farmakis, Anastasia Prodromidou, Apostolos Raptis, Elias Efstathiou, John Spiliotis, Nikolaos Kopanakis
Publikováno v:
Surgical Innovation. :155335062095825
Autor:
Iuliana Toma-Dasu, Alexandru Dasu, Anna M. Flejmer, Apostolos Raptis, Oscar Ardenfors, Jakob Ödén
Publikováno v:
Physica Medica
Background The reduced normal tissue dose burden from protons can reduce the risk of second cancer for breast cancer patients. Breathing motion and the impact of variable relative biological effectiveness (RBE) are however concerns for proton dose di